These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8231445)

  • 21. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
    Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
    J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of third-generation cephalosporins in human blood.
    Shah PM; Jaenisch E
    Clin Ther; 1983; 6(1):72-8. PubMed ID: 6325006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of ozone on the susceptibility of Escherichia coli K1 to the bactericidal action of serum.
    Jankowski S; Cisowska A; Doroszkiewicz W
    Folia Microbiol (Praha); 1996; 41(5):395-400. PubMed ID: 9131796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum resistance of Escherichia coli and serum bactericidal activity in chronic pyelonephritis].
    Falkenhagen U; Handschuck I; Nimmich W; Zingler G; Naumann G
    Z Urol Nephrol; 1984 Nov; 77(11):629-38. PubMed ID: 6395557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
    Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
    J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytopathogenic effect of E. coli cells containing heterogeneous human O(H) type antigen on human cells in culture].
    Kochergina NI; Bochko GM; Podoplelov II
    Biull Eksp Biol Med; 1977 Jul; 84(7):70-2. PubMed ID: 329916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary bactericidal activity of single doses (250, 500, 750 and 1000 mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli.
    Stein GE; Schooley SL; Nicolau DP
    Int J Antimicrob Agents; 2008 Oct; 32(4):320-5. PubMed ID: 18715762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytopathogenic action of E. coli strains, containing corresponding ABO type heterogeneous antigens, on transplantable human cells].
    Podoplelov II; Kriukova GV; Samoĭlenko AS
    Biull Eksp Biol Med; 1976 May; 81(5):568-70. PubMed ID: 779867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K antigen and serum sensitivity of rough Escherichia coli.
    Opal S; Cross A; Gemski P
    Infect Immun; 1982 Sep; 37(3):956-60. PubMed ID: 6752031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic killing of gram-negative bacilli by cefotaxime, its desacetyl metabolite and human polymorphonuclear neutrophils.
    Mandell LA; Afnan M
    J Antimicrob Chemother; 1991 Jun; 27(6):817-28. PubMed ID: 1938688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of culture conditions on the susceptibility of enteroaggregative Escherichia coli to human serum and polymorphonuclear leucocytes.
    Haque MA; Kohashi O
    Microbios; 1996; 86(349):213-23. PubMed ID: 8893523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation, molecular characterization and antimicrobial resistance patterns of Salmonella and Escherichia coli isolates from meat-based fast food in Lebanon.
    Harakeh S; Yassine H; Gharios M; Barbour E; Hajjar S; El-Fadel M; Toufeili I; Tannous R
    Sci Total Environ; 2005 Apr; 341(1-3):33-44. PubMed ID: 15833239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K1 antigen, serotype and antibiotic susceptibility of Escherichia coli isolated from cerebrospinal fluid, blood and other specimens from Japanese infants.
    Fujita K; Yoshioka H; Sakata H; Murono K; Kakehashi H; Kaeriyama M; Tsukamoto T
    Acta Paediatr Jpn; 1990 Dec; 32(6):610-4. PubMed ID: 2082663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic modification of the reactivity in human serum of Escherichia coli K1 isolates.
    Livey I; White GC; Taylor PW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(4):457-63. PubMed ID: 6398567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
    Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefotaxime: rate of bacterial killing and interactions with serum and leukocyte activity.
    Gialdroni Grassi G; Mangiarotti P; Fietta A
    Acta Med Port; 1983 Mar; 4(3):167-71. PubMed ID: 6305143
    [No Abstract]   [Full Text] [Related]  

  • 40. [Avian pathogenic Escherichia coli (APEC)].
    Ewers C; Janssen T; Wieler LH
    Berl Munch Tierarztl Wochenschr; 2003; 116(9-10):381-95. PubMed ID: 14526468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.